KPV 10mg is a higher-capacity anti-inflammatory tripeptide formulation designed for extended preclinical investigations of immune regulation and therapeutic mechanisms. This quantity supports comprehensive dose-response studies and longer-duration inflammatory response and regulatory pathway research protocols across multiple model systems.

Chemical Compound Information:

• Chemical Name: KPV (lysine-proline-valine tripeptide derivative)
• Molecular Formula: C₁₄H₂₆N₄O₃
• Molecular Weight: ~294.39 Da
• Compound Class: Tripeptide; melanocortin receptor signaling modulator

Description:
The 10mg KPV formulation provides sufficient material for comprehensive immune and inflammatory research studies. This quantity enables systematic investigation of anti-inflammatory mechanisms, dose-dependent immune cell effects, and detailed characterization of tripeptide signaling in multiple preclinical model systems.

Research Applications:

• Comprehensive dose-response profiling of KPV effects on inflammatory markers and cytokine production
• Investigation of tripeptide pharmacodynamics in acute and chronic exposure paradigms
• Study of KPV effects on T-regulatory cell differentiation and expansion mechanisms
• Assessment of tripeptide modulation of intestinal barrier integrity and tight junction proteins
• Evaluation of combined KPV effects with other immune-modulating agents in co-treatment models

Storage and Handling:

• Maintain powder at -20°C in tightly sealed, moisture-protected vials
• Prepare solutions in sterile water or appropriate buffer solutions before use
• Store working solutions at 2-8°C; utilize within 48 hours
• Minimize freeze-thaw exposure; employ single-use aliquots when feasible

Product Specifications:

• Purity: ≥98% by HPLC
• Form: Lyophilized powder
• Quantity: 10mg per vial
• Appearance: Fine white powder

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.